20 May 2013
Keywords: yamanouchi, merck, link-up, drugs, japan, kgaa, struck
Article | 21 May 1998
Yamanouchi of Japan and Merck KGaA have struck a codevelopment deal ontwo new cardiovascular drugs; YM103/EMD96785, an Na+/H+ ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 May 1998
20 May 1998
17 May 2013
© 2013 thepharmaletter.com